Brookstone Capital Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-14,994
Closed -$4.12M 833
2023
Q2
$4.12M Buy
14,994
+3,411
+29% +$1.02M 0.08% 221
2023
Q1
$3.38M Buy
11,583
+2,944
+34% +$815K 0.07% 244
2022
Q4
$2.41M Buy
8,639
+1,404
+19% +$397K 0.05% 280
2022
Q3
$1.83M Buy
7,235
+2,242
+45% +$476K 0.04% 300
2022
Q2
$1.09M Buy
4,993
+926
+23% +$189K 0.02% 387
2022
Q1
$857K Buy
4,067
+1,909
+88% +$415K 0.02% 446
2021
Q4
$502K Buy
2,158
+409
+23% +$105K 0.01% 526
2021
Q3
$496K Buy
1,749
+1,073
+159% +$352K 0.01% 502
2021
Q2
$238K Buy
+676
New +$205K ﹤0.01% 641
2015
Q4
Sell
-25
Closed -$7K 231
2015
Q3
$7K Sell
25
-17
-40% -$5.61K ﹤0.01% 1279
2015
Q2
$17K Buy
+42
New +$16.9K ﹤0.01% 936

Other funds holding BIIB